OA vs LORA: Know the Difference! www.thecurbsiders.com Not all joint pain is the same. 🦴 ➡️ Swipe through to see how osteoarthritis (OA) differs from late-onset rheumatoid arthritis (LORA)—from where it shows up to how it’s treated. With expert guest @unamakris.bsky.social

Thank you to UTSW Rheumatology for hosting me the past few days. I enjoyed meeting folks in Rheum & other Div/Depts, & engaging in micro-mentoring. I think I got people interested in #osteoarthritis, pain mechanisms, & #gout! I’m looking forward to new collaborations! @unamakris.bsky.social

Viewpoint: Recent disruptions and funding cuts at the NIH undermine the infrastructure and stability of US scientific research, threatening the nation's global leadership and scientific productivity. https://ja.ma/3FLvqHS

American Science in Peril

This Viewpoint discusses the importance of federal funding of biomedical research from the National Institutes of Health to scientific discovery, advancements in individual and public health, and the support of the US’ community of scientists.

ja.ma

Great weekend #RNL2025 Speaking about geriatrics concepts we can integrate into our care to improve outcomes for older adults with rheumatic disease. Thank you to this engaged audience early Sat morning 🙌🙌 @rheumnow.bsky.social @kwyshammd.bsky.social Credit to #gerirheum for moving us forward

B England 75% of RA pts have multi-morbidity Pts develop multi-morbidity BEFORE the onset of RA Should we have different goals: Prioritize LDA over remission in pts w multimorbidity Collaborate w PCP: one size doesn't fit all, do something better than nothing! @rheumnow.bsky.social #RNL2025

Review Med Lists in Rheum - ~40% of pts w RA/SLE on Potentially Inappropriate Meds (PIM) -Review Beers Criteria for Rx to avoid in older pts - Include: antidepress, benzo, steroid + NSAID, gaba, nifed, PPI, mm relax @unamakris.bsky.social at #RNL2025 @rheumnow.bsky.social @JihaRheum @NamrataRheum

@unamakris.bsky.social #RNL25 @rheumnow.bsky.social Older pts w RA 1/3 of pts onset >60-65 - More acute onset, more systemic, more PMR-like, larger jts - Higher IL-6, lower TNF-a, less RF, high ESR -Co-morbidities, polypharmacy, cognition, depression Age does not equal frailty, but does correlate

J Curtis #RNL2025 @rheumnow.bsky.social AI Will Not Replace You - AI cannot replace human interaction, examination, procedures, interpreting guidelines for an individual, providing empathy, and facilitate good patient education Will become a tool... but not a replacement to a good clinician

Both an integrated pain team and pharmacist collaborative management resulted in similar small improvements in pain and substantial reductions in opioid dosage among chronic pain patients on long-term opioid therapy. ja.ma/3VttRDz @jama.com

Care Models to Improve Pain and Reduce Opioids Among Patients Prescribed Long-Term Opioid Therapy

This randomized clinical trial compares the effectiveness of an integrated pain team vs pharmacist collaborative management on pain and opioid dosage.

ja.ma

Assessing agreement of frailty measures and association with health outcomes over 3 years found percentages of individuals classified as frail and agreement of frailty classification varied widely. Most measures were predictive of poor health outcomes In AC&R doi.org/10.1002/acr....

Measuring Frailty in Systemic Lupus Erythematosus

Objective Recent research has explored frailty in systemic lupus erythematosus (SLE) using multiple measures. We examined the agreement among frailty measures and the association of each with cross-...

doi.org

Fantastic collaboration amongst medical specialists around #frailty @clinstarcc.bsky.social @agsjournal.bsky.social agsjournals.onlinelibrary.wiley.com/doi/10.1111/...

Frailty integration in medical specialties: Current evidence and suggested strategies from the Clin‐STAR frailty interest group

Frailty is a syndrome that can inform clinical treatments and interventions for older adults. Although implementation of frailty across medical subspecialties has the potential to improve care for th...

agsjournals.onlinelibrary.wiley.com

www.thelancet.com/series/agein... Proud of this series on aging, thank you for the opportunity to highlight what is known (and what is not) in aging and rheumatic diseases #gerirheum #acr24 #ClinSTAR2024 @utswinternalmed.bsky.social @thelancet.bsky.social

Lessons learned from advancing aging research in Rheumatology. Proud of my #gerirheum colleagues for moving our field forward #ClinSTARCC #ClinSTAR2024 #AFARorg #NIHAging #acr24

More from DC and #ACR24 #gerirheum

Fun in DC for #ACR24 love my 2 communities of rheum and geriatrics

Reflecting on a fantastic #ACR24 for both the science and reconnecting with so many dear colleagues and friends #gerirheum

Pros and cons of leading a #NIH network grant or conference grant #ClinSTAR2024 w/ Drs. Sharon Inouye @manish-shah.bsky.social Basil Eldadah, William Dale #R13 #R24 #R33

Now @unamakris.bsky.social rheumatologist about how to be a specialist with an #aging focus #Beeson2024 - create learning opportunities like journal clubs - identify diverse funding sources - attend special interest group meetings for your specialty relevant to aging - submit proposals to symposia

Now at #ClinSTAR2024 Dr. Sharon Inouye, MD, MPH, Editor-in-Chief of @jamacurrent.bsky.social Internal Medicine sharing tips on "Publishing in Academic Medicine: A Few Pearls to Enhance Success" 🧵